Dynavax Technologies Corporation
USPTO PatentsView assignee record - 31 granted patents across 10 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Dynavax ranks #10,015 of 49,997 tracked US assignees by granted-patent volume, with 31 patents across 10 technology areas.
- #10,015
- of 49,997 US assignees by volume
- Top 34%
- by Innovation Score (41.1/100)
- 24.9
- avg claims per patent
- -53%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R10015 · US Corporation #10,015 · 31 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
- GRANTS-SMALL 31 grants
- UPPER-Q #10,015/49,997
- PHOTO-FINISH Dehn SE
- CPC-FOCUS A61P · 10 areas
- INNOV-PAR 41.1/100
- CLAIMS-DENSE 24.9 claims/avg
- TYPE-USCORP US Corporation
- VEL-DROP -53% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Dehn SE (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Dynavax’s 41.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Dynavax
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Ajax Systems Cyprus… · near
Ajax Systems Cyprus… · near
41 score
- Brooks Automation… · near
Brooks Automation… · near
41 score
- Dynavax · this assignee
Dynavax · this assignee
41 score
- Energesis Pharmaceut… · near
Energesis Pharmaceut… · near
41 score
- Gaps Technology · near
Gaps Technology · near
41 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Dynavax's Innovation Score is 41.1/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Dynavax?
Each dot is one of Dynavax’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dynavax’s own 24.9 claims/patent is ABOVE the 18.4 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Dynavax's grants concentrate
Dynavax Technologies Corporation is a focused PatentsView assignee: 10 CPC subclasses with 93.5% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2016 (6 grants) versus a trough of 1 in 2021. By volume, Dynavax sits between Dehn SE and Erema Engineering Recycling Maschinen UND Anlagen Gesellschaft, M.B.H..
Dynavax's three-year grant acceleration
Dynavax Technologies Corporation shows 4 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Dynavax's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Dehn SE
Dehn SE
31 patents
- Dowco
Dowco LLC
31 patents
- Draftkings
Draftkings, Inc.
31 patents
- Dubrosky & Tracy…
Dubrosky & Tracy Patent Service Corp.
31 patents
- Delphix
Delphix Corp.
31 patents
- E ON Sverige AB
E.ON Sverige AB
31 patents
- Emseal Joint Syst…
Emseal Joint Systems, Ltd.
31 patents
- Erema Engineering…
Erema Engineering Recycling Maschinen UND Anlagen Gesellschaft, M.B.H.
31 patents
- Dynavax ◀
Dynavax Technologies Corporation
31 patents
What this shows Dynavax holds 31 patents at rank #10,014, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Dynavax
By rank, the assignees closest to #10,014 in granted patent volume.
- Dehn SE #10,010 · 31 patents
- Dowco LLC #10,011 · 31 patents
- Draftkings, Inc. #10,012 · 31 patents
- Dubrosky & Tracy Patent Service Corp. #10,013 · 31 patents
- Delphix Corp. #10,015 · 31 patents
- E.ON Sverige AB #10,016 · 31 patents
- Emseal Joint Systems, Ltd. #10,017 · 31 patents
- Erema Engineering Recycling Maschinen UND Anlagen Gesellschaft, M.B.H. #10,018 · 31 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Dynavax's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Dynavax, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Dynavax ranks #678 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (41 here).
Dynavax's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 4 | 12.9% |
| 2016 | 6 | 19.4% |
| 2018 | 5 | 16.1% |
| 2019 | 4 | 12.9% |
| 2020 | 4 | 12.9% |
| 2021 | 1 | 3.2% |
| 2022 | 1 | 3.2% |
| 2023 | 2 | 6.5% |
| 2024 | 1 | 3.2% |
| 2025partial year | 3 | 9.7% |
Which technologies does Dynavax Technologies Corporation patent most?
Top 10 of 10 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Dynavax Technologies Corporation's patent record in context - here's where to go next.
- Dynavax Technologies Corporation's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 93.5% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #10,015 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Dynavax Technologies Corporation against Dehn SE, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 41.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.